9 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.

Bristol-Myers Squibb
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.

Chemocentryx
Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesis.

Bristol-Myers Squibb
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.

Novartis Institutes For Biomedical Research
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.

Incyte
Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.

Tanabe Research Laboratories
Design, synthesis, and discovery of a novel CCR1 antagonist.

Banyu Tsukuba Research Institute In Collaboration With Merck Research Laboratories